<p>The first bar (2005) depicts carriage prevalence before implementation of PCV. The following four bars depict carriage prevalence as observed during the follow-up studies; respectively 3 years after PCV7 implementation (2009), 4.5 years after PCV7 implementation and immediately before introduction of PHiD-CV10 (2010/2011), 1.5 years after PHiD-CV10 implementation (2012/2013) and 4.5 years after PHiD-CV10 implementation (2015/2016).</p
AbstractBackgroundChanges in serotype distribution have been induced after pneumococcal conjugate va...
Objectives Burden of pneumococcal disease depends on the prevalence and invasive disease potential o...
After introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in the infant national immu...
<p>PCV7 serotypes include serotypes 4, 6B, 9V, 14, 18C, 19F and 23F. PHiD-CV10 shows the additional ...
<p><b>Serotype distribution of IPD in children (<5 years) (A) and older adults (>65 years) (B).</b> ...
The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in The Netherlands in 2006 and was...
The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in The Netherlands in 2006 and was...
BACKGROUND:Routine immunisation with pneumococcal conjugate vaccines (PCV7/10/13) has reduced invasi...
Background: asymptomatic carriage of the opportunistic pathogen Streptococcus pneumoniae is known to...
To evaluate the effectiveness of the 7-valent pneumococcal conjugate vaccine (PCV7) program, we cond...
To evaluate the effectiveness of the 7-valent pneumococcal conjugate vaccine (PCV7) program, we cond...
Periodic cycles in the serotype-specific incidence of invasive pneumococcal disease have been descri...
Streptococcus pneumoniae is a major cause of meningitis, sepsis and pneumonia worldwide. Vaccination...
We evaluated invasive pneumococcal disease (IPD) during 8 years of infant pneumococcal conjugate vac...
<p>Black bars: serotypes included in the PCV-7. Grey bars: additional serotypes included in the PCV-...
AbstractBackgroundChanges in serotype distribution have been induced after pneumococcal conjugate va...
Objectives Burden of pneumococcal disease depends on the prevalence and invasive disease potential o...
After introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in the infant national immu...
<p>PCV7 serotypes include serotypes 4, 6B, 9V, 14, 18C, 19F and 23F. PHiD-CV10 shows the additional ...
<p><b>Serotype distribution of IPD in children (<5 years) (A) and older adults (>65 years) (B).</b> ...
The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in The Netherlands in 2006 and was...
The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in The Netherlands in 2006 and was...
BACKGROUND:Routine immunisation with pneumococcal conjugate vaccines (PCV7/10/13) has reduced invasi...
Background: asymptomatic carriage of the opportunistic pathogen Streptococcus pneumoniae is known to...
To evaluate the effectiveness of the 7-valent pneumococcal conjugate vaccine (PCV7) program, we cond...
To evaluate the effectiveness of the 7-valent pneumococcal conjugate vaccine (PCV7) program, we cond...
Periodic cycles in the serotype-specific incidence of invasive pneumococcal disease have been descri...
Streptococcus pneumoniae is a major cause of meningitis, sepsis and pneumonia worldwide. Vaccination...
We evaluated invasive pneumococcal disease (IPD) during 8 years of infant pneumococcal conjugate vac...
<p>Black bars: serotypes included in the PCV-7. Grey bars: additional serotypes included in the PCV-...
AbstractBackgroundChanges in serotype distribution have been induced after pneumococcal conjugate va...
Objectives Burden of pneumococcal disease depends on the prevalence and invasive disease potential o...
After introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in the infant national immu...